Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 7;6(1):2.
doi: 10.1186/s41181-020-00117-6.

Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators

Affiliations

Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators

Cyril Fersing et al. EJNMMI Radiopharm Chem. .

Abstract

Background: The purpose of this work was to design, validate and implement a media-fill test combined with fluorescein (MFT-F) for the specific qualification and training of radiopharmacy operators, in accordance with United States Pharmacopeia General Chapter 797 and European Good Manufacturing Practices. MFT-F was embedded in the quality management system of our radiopharmacy unit. Its validation involved fluorescein concentration choice, media growth promotion test and evaluation protocol controls (with or without intentional aseptic mistakes). Each operator was evaluated following a three-part evaluation form. Evaluation criteria related to garbing and hygiene, fluorescent contamination and bacteriological contamination (pre- and post-evaluation environment controls and MFT-F samples). Combined MFT-F allowed the assessment of aseptic compounding skills and non-contamination of the working area through a single evaluation. It was also designed to fit the constraints of radiopharmacy common practice related to radiation protection equipment and to the small volumes handled.

Results: A 0.01% fluorescein concentration was chosen to prepare MFT-F. Addition of fluorescein in the culture medium did not jeopardize its growth properties according to growth promotion test. Eleven operators were evaluated and carried out 3 MFT-F over 3 successive days. Pre- and post-evaluation bacteriological controls of every session showed no CFU of microbiological contaminant above 5. All operators validated the garbing and hygiene evaluation, with an average score of 92.7%. All operators validated the fluorescent contamination evaluation, with an average score of 29.4 out of 30. None of the MFT-F samples showed any visible bacterial growth after incubation.

Conclusions: Combined MFT-F, as a part of a comprehensive sterile compounding training program, appeared as a convenient and promising tool to increase both the sterile compounding safety and awareness of radioactive contamination in radiopharmacy.

Keywords: Fluorescein; Good radiopharmacy practices; Media-fill test; Operators qualification; Sterile compounding.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Fig. 1
Fig. 1
preparation of tsb-f vials
Fig. 2
Fig. 2
cartographic representation of the lead-shielded cell working area showing the locations determined for pre- and post-evaluation bacteriological controls
Fig. 3
Fig. 3
first and second parts of the operator evaluation form
Fig. 4
Fig. 4
mft-f operating procedure

References

    1. Amalric P. Fluorescein angiography: international symposium, Albi, 1969: Proceedings S Karger AG. 1972.
    1. Baab DA, Broadwell AH, Williams BL. A comparison of antimicrobial activity of four disclosant dyes. J Dent Res. 1983;62:837–841. doi: 10.1177/00220345830620071601. - DOI - PubMed
    1. Biechlin M-L, Léger S, Vial F, Desruet M-D. How to combine hygiene and radiation protection for radiopharmaceuticals preparation? Analysis in France and propositions. Nucl Med Commun. 2007;28:876–878. doi: 10.1097/MNM.0b013e3282f03bf5. - DOI - PubMed
    1. Bouche T, Auzou M, Daurel C, Quintyn J, Join-Lambert O, Guérin F. In vitro evaluation of the antibacterial activity of fluorescein® 0.5% eye drops. Acta Ophthalmol. 2019;98:e260–e261. doi: 10.1111/aos.14204. - DOI - PubMed
    1. Council of Europe, 2018 . European Pharmacopoeia 9th Ed. Main Volume 9.6 2.6.1: Sterility. 2018.

LinkOut - more resources